ChiCTR2200055831
Untitled Trial
Clinical study of eilamod on bone protection and evaluation of muscle bone ultrasound in rheumatoid arthritis complicated with osteopenia
Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University·Phase 4·Chinese Clinical Trial RegistryNot yet recruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Rheumatoid arthritis
Sponsor & location
- Primary sponsor
- Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University
- Location
- China
Timeline & enrollment
- Phase
- Phase 4
- Start date
- N/A
- End date
- Feb 01, 2023
ICD-10 classifications
Rheumatoid arthritis, unspecifiedOther rheumatoid arthritisOther specified rheumatoid arthritisRheumatoid arthritis with involvement of other organs and systemsSeronegative rheumatoid arthritis
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2200055831
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2200055831 through Pure Global AI's free database. This Phase 4 trial is sponsored by Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University and is currently Not yet recruiting. The study focuses on Rheumatoid arthritis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.